Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 3/20 | 0.43 |
| ▸ | RIPK2 | O43353 | 5/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13997025 | 0.93 | XDH (0.42) | XDHKMT2APTGS1PTGS2SMN1; SMN2 | |
| SCHEMBL25845511 | 0.92 | XDH (0.39) | XDH | |
| SCHEMBL13456834 | 0.92 | XDH (0.39) | XDH | |
| SCHEMBL13430520 | 0.92 | XDH (0.39) | XDH | |
| SCHEMBL13430516 | 0.86 | XDH (0.40) | XDHSMN1; SMN2 | |
| SCHEMBL13144685 | 0.86 | XDH (0.34) | XDH | |
| SCHEMBL13430512 | 0.85 | XDH (0.40) | XDHPTGS1PTGS2SMN1; SMN2 | |
| SCHEMBL15694828 | 0.83 | XDH (0.38) | XDHRIPK2KMT2AF2PTGS1 | |
| SCHEMBL14227878 | 0.83 | XDH (0.34) | XDHSMN1; SMN2 | |
| SCHEMBL15694830 | 0.82 | XDH (0.37) | XDHRIPK2KMT2AF2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100063262-A1 | PROCESS FOR PRODUCING 5-AMINOPYRAZOLE DERIVATIVE, AND AZO DYE | FUJIFILM CORPORATION (JP) | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063262-A1 | PROCESS FOR PRODUCING 5-AMINOPYRAZOLE DERIVATIVE, AND AZO DYE | H1-5, CYP3A5, IL5 | XDH 100/4885RIPK2 2668/4885KMT2A 609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.